Step 1 of 2
As oral targeted therapies for HR-positive/HER2-negative breast cancer expand, nurses need practical guidance to identify and manage overlapping adverse events, support treatment adherence, and help patients achieve the full benefit of therapy. These downloadable slides summarize indications, dosing, and administration of approved oral targeted agents along with nursing-focused clinical pearls related to AE monitoring and management.